Literature DB >> 2734549

Comparison of metabolically labeled mucins of LS174T human colon cancer cells in tissue culture and xenograft.

B Siddiqui1, J C Byrd, F J Fearney, Y S Kim.   

Abstract

Colon cancer cells in culture synthesize and secrete mucin glycoproteins, which carry a number of cancer-associated antigens. However, the structures and mechanisms of biosynthetic processing are not well understood. Mucins synthesized and secreted by LS174T human colon cancer cells were compared to those in LS174T xenografts in athymic mice. Mucins radiolabeled with glucosamine or sulfate were purified by gel filtration and cesium chloride density gradient centrifugation. The mucins were of high molecular weight and were resistant to chondroitinase ABC, hyaluronidase and HNO2 treatment. They were, however, susceptible to pronase digestion and mild alkaline treatment. Using radiochemical precursors, the cellular mucin was shown to contain fucose, galactose, N-acetylgalactosamine, N-acetylglucosamine, N-acetylneuraminic acid, and sulfate. Oligosaccharides released by beta-elimination had N-acetylgalactosaminitol as the reduced amino sugar and also unreduced galactosamine, indicating that there is N-acetyl-galactosamine O-glycosidically attached to protein core and also peripheral N-acetyl-galactosamine not directly linked to protein. DEAE-cellulose chromatography of mucins showed two major peaks with both intracellular and secreted mucins, but xenograft mucins also had more acidic components. Sulfate-labeled mucins were shifted to less acidic peaks by neuraminidase digestion, which indicates that the same mucin molecules are both sialylated and sulfated. We conclude that the intracellular mucins of cultured colon cancer cells, those secreted into the medium, and those in nude mouse xenografts are chemically similar, but differ in sialic acid and sulfate content. This experimental model system, LS174T cells maintained in culture and as nude mouse xenografts, may be useful for further biosynthetic and structural studies of colon cancer mucin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734549     DOI: 10.1159/000217600

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  6 in total

1.  Differential mucin gene expression in human pancreatic and colon cancer cells.

Authors:  S Yonezawa; J C Byrd; R Dahiya; J J Ho; J R Gum; B Griffiths; D M Swallow; Y S Kim
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Characterization of mucin glycoprotein-specific translation products from swine and human trachea, pancreas and colon.

Authors:  S Sangadala; P Wallace; J Mendicino
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

3.  Biosynthesis of two distinct types of mucin in HM3 human colon cancer cells.

Authors:  S Ohara; J C Byrd; J R Gum; Y S Kim
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

4.  Synthesis and secretion of mucin by the human colonic tumour cell line LS180.

Authors:  D J McCool; J F Forstner; G G Forstner
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

5.  Entamoeba histolytica-Induced Mucin Exocytosis Is Mediated by VAMP8 and Is Critical in Mucosal Innate Host Defense.

Authors:  Steve Cornick; France Moreau; Herbert Y Gaisano; Kris Chadee
Journal:  mBio       Date:  2017-10-03       Impact factor: 7.867

6.  VAMP8-mediated MUC2 mucin exocytosis from colonic goblet cells maintains innate intestinal homeostasis.

Authors:  Steve Cornick; Manish Kumar; France Moreau; Herbert Gaisano; Kris Chadee
Journal:  Nat Commun       Date:  2019-09-20       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.